Tech Company Financing Transactions
Zylo Therapeutics Funding Round
Zylo Therapeutics, operating out of Greenville, secured $4 million in funding from VentureSouth, Ariel Southeast Angel Partners and Boston Harbor Angels.
Transaction Overview
Company Name
Announced On
9/27/2019
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to further scale up the manufacturing process of its Z-pod delivery particles and for general working-capital and business-development purposes.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
200 Patewood Dr. Building C 400
Greenville, SC 29615
USA
Greenville, SC 29615
USA
Phone
Website
Email Address
Overview
Zyl Therapeutics has an innovative sustained-release drug-delivery system that was developed by Joel Friedman MD PhD, Adam Friedman MD FAAD, and Andrew Draganski PhD. The delivery system uses patented hydrogel-derived nanoparticles, called Nanopods, to deliver--in a sustained and controlled manner--notoriously hard-to-deliver therapeutic agents through topical administration.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Pancoast
VP - Bus. Development
Michael Rabin
Browse more venture capital transactions:
Prev: 9/27/2019: StrongSalt venture capital transaction
Next: 9/27/2019: Teampay venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs